efficacy

Study: Covishield is similar to AstraZeneca England in efficacy

Chandigarh: Covishield is produced in India similar in terms of security and immunogenicity against the English version produced by AstraZeneca.This…

3 years ago

Hong Kong Approved Covaxin Bharat Biotech

Hong Kong: Hong Kong has identified the Hyderabad-based pharmaceutical company Bharat Biotech's vaccine Covid Covaxin on the list of 19…

3 years ago

Covaxin ‘is very suitable’ for low-income countries low because of easy storage requirements: Who

Geneva: World Health Organization (WHO) said that Covaxin - Covid-19 vaccine developed by Bharat Biotech - is very suitable for…

3 years ago

Covid-19: Why scientists feel the photo of the vaccine amplifier is not ‘according to’ at this stage

New Delhi: The shooting of the Covid-19 vaccine amplifier is not in accordance with this stage in a pandemic, according…

3 years ago

Not considering a proposal to reduce the gap between two covid vaccine doses, the government said

New Delhi: The current government does not consider a proposal to reduce the gap between two covid vaccine doses, the…

3 years ago

China Approved the First Mixed Vaccine Test when Delta Spreads

Beijing: China's drug regulator has approved the country's first mixed vaccine trial, a company involved in the study said, because…

3 years ago

Bharat Biotech is committed to supplying 500 million doses of covaxin to the center of the immunization program

Hyderabad: Bharat Biotech on Friday said it has committed to supply more than 500 million doses of covid-19 covaxin vaccine…

3 years ago

Ocugen Started Rolling Submission to Canadian Health for Covaxin

Hyderabad: Ocugen Inc.partner, Bharat Biotech partner for us and Canada, said on Thursday that it has initiated a rolling submission…

3 years ago

The efficacy of the overall Covaxin 77.8%, 65.2% effective against Delta variants: Bharat Biotech

Hyderabad: Covaxin the first Covid-19 vaccine developed by original India as a whole of 77.8% effective against Covid-19 and 65.2%…

3 years ago

1 dose of covid vaccine provides 92%, two 98% protection against death: study

New Delhi: Single Dosage Covid-19 Vaccine has shown 92% efficacy in protecting against death, whereas with two doses increasing to…

3 years ago